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CHAPTER I:  INTRODUCTION  
BACKGROUND  
Lipid 654 
Lipid 654 is a serine dipeptide lipid originally identified as Flavolipin in Flavobacteria (Figure 
1).  Lipid 654 has been demonstrated to play a role in the development of two chronic 
inflammatory diseases, including periodontal disease and atherosclerosis. Most recently, studies 
have shown that Lipid 654 may be implicated in the development of multiple sclerosis1.  While 
the link between infectious agents and autoimmune disease is still controversial, there have been 
numerous examples of gut microbes playing a role in systemic diseases such as Crohn’s disease2 
and diabetes mellitus3.   
 
 
 
 
 
Figure 1.  Structures of Lipid 654 and Lipid 430. 
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Lipid 654 is produced by Bacteroidetes species of the gut and oral cavity and can be detected in 
the serum of healthy individuals.  Members of the Bacteroidetes phylum are considered to 
commensal organisms in the gut but some are considered to be pathogens when identified in 
subgingival plaque.  While Lipid 654 was originally reported to be a TLR4 ligand,4,5 it was more 
recently discovered that Lipid 654 acts by engaging TLR2 and TLR2 co-receptors including 
TLR6 and CD-146 as seen in Figure 2.  In experiments by Clark et al., Lipid 654 was shown to 
activate TLR2-expressing HEK cells6.  Furthermore, this activation could be inhibited by 
treatment with neutralizing anti-TLR2 antibody.  When the same experiment was carried out on 
TLR4-expressing HEK cells, the cells failed to be activated by Lipid 654.  It was also 
demonstrated that wild-type mice injected with Lipid 654 had increased serum levels of 
chemokine CCL2 when measured four hours later.  The same Lipid 654 injections resulted in no 
increase in serum CCL2 when administered to TLR2(-/-) knockout mice.   
Figure 2. Lipid 654 (L654) effects on HEK cells stably transfected to express human TLR2.  
Cells were treated with either PBS (Controls) or P. gingivalis L654 (1 ug/ml) with or 
without the indicated neutralizing antibodies.   This evidence shows that L654 engages 
TLR2 co-receptors and TLR6, in a manner similar to known diacylated  lipoproteins 
(Pam2Cys but not Pam3 Cys).  
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Patients with multiple sclerosis are reported to have lower serum levels of Lipid 654.1  These 
patients also show upregulation and increased expression of TLR2 on oligodendrocytes and 
peripheral blood mononuclear cells (PBMCs)7,8.  Some authors have suggested that these two 
pieces of information, taken together, suggest that the presence of Lipid 654 in the circulation 
may act as a mechanism to mediate TLR2 tolerance9.  Whether Lipid 654 plays a role in 
promoting inflammation or maintaining immune tolerance, there is a clear need to better 
understand the pathways through which Lipid 654 mediates the interaction between gut 
microbiome and host. 
As it pertains to its presence in the oral cavity, Lipid 654 has also been implicated in the 
pathogenesis of periodontal disease.  For example, Lipid 654 isolated from lyophilized P. 
gingivalis samples has been demonstrated to play a role in inflammatory disease via inhibition of 
osteoblast differentiation10.  In these experiments, performed by Wang et al, osteoblasts were 
obtained from calvaria of wild-type or TLR2 knockout mouse pups that were genetically 
engineered to express Col2.3GFP transgene.  Osteoblast function as well as osteoblast 
differentiation were then monitored by von Kossa stained mineral deposits and GFP fluorescence 
and gene expression respectively.  These experiments showed that GFP expression, osteoblast 
gene expression, and mineral nodule formation were all significantly inhibited by Lipid 654.  
Furthermore, this inhibition was shown to be dependent on TLR2 engagement.   
Despite the links established by a finding such as this, Lipid 654 extracts from gingival tissue 
samples showed relatively similar levels of Lipid 654 in both diseased and healthy tissues.  If 
Lipid 654 were to be playing a key role in the disease process, one would expect to find 
increased levels in diseased tissues.  At first, this might appear to indicate that Lipid 654 does not 
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play a role in periodontal disease.  However, a closer look at other properties of Lipid 654 seem 
to explain this phenomenon.   
To understand why Lipid 654 levels may be similar in both diseased and healthy gingival tissues, 
it is important to note that two isoforms of Lipid 654 may exist in bacterial Lipid 654 extracts.  
These isoforms are enantiomers differing in the R and S configuration in the beta carbon of the 3-
OH iso C17:0 fatty acid.  The key difference between these isoforms is that the R form can be 
hydrolyzed to generate another important lipid: Lipid 430.  As it turns out, this difference may be 
crucial to the pathogenicity of Lipid 654.   
Lipid 430 
Lipid 430 (Figure 1) is a de-esterified hydrolysis product of Lipid 654.  Hydrolysis of Lipid 654 
to Lipid 430 is reported to be enzymatically catalyzed by phospholipase A2 (PLA2) (see Figure 
3).  The fact that phospholipase A2 hydrolyzes Lipid 654 is a significant finding in itself due to 
the fact that Lipid 654 is not a phospholipid and does not contain a glycerol moiety (see Figure 
1).  Much like Lipid 654, Lipid 430 has been demonstrated to activate TLR2 expressing HEK 
cells, but not TLR4 expressing HEK cells6.  The activation of the former can also be inhibited by 
anti-TLR2 antibodies.  Lipid 430 also increases serum CCL2 levels of wild-type mice, but does 
not increase serum CCL2 levels when injected into TLR2 –deficient mice.  Lipid 430 was also 
demonstrated to inhibit both osteoblast differentiation and function, just as Lipid 654.  In the 
same experiments as those mentioned above, Lipid 430 was shown to inhibit osteoblast gene 
expression and mineral nodule formation10.  Of great importance, Lipid 430 was also shown to 
stimulate TNF-α and RANKL gene expression in wild-type cells.  Stimulation of TNF-α and 
RANKL gene expression did not occur in TLR2 knockout cells.  These conclusions led 
5 
 
investigators to conclude that Lipid 654 and Lipid 430 have the ability to promote bone loss in a 
TLR2 dependent manner in periodontitis. 
Figure 3.  Hydrolysis of synthetic L654 by a commercially available preparation of human 
recombinant secretory PLA2.  Enantioenriched R or S synthetic L654 preparations were 
prepared by Dr. Mike Smith and Mr. Chris Dietz of the Department of Chemistry at the 
University of Connecticut.  Aliquots of synthetic R or S L654 (250 ng) were sonicated in 
buffer (1 ml of 10 mM Tris, pH 7.5, 2.5 mM CaCl and 150 mM NaCl) for 20 sec and after 
adding 5ug of human recombinant secretory PLA2 (Cayman Chemical, >95% purity), 
samples were stirred at 37°C for up to 24 hours.   Controls received no enzyme.  Samples 
were then acidified with 25 l of acetic acid and extracted three times with chloroform.  
Extracts were pooled, dried and reconstituted in HPLC solvent. L654 and L430 were 
quantified using multiple reaction monitoring mass spectrometry (LC-MRM MS) as 
previously reported 1.  Figure 5 shows hydrolysis of only the R synthetic 654.  We also 
evaluated honey bee venom PLA2 and porcine pancreatic PLA2 (Sigma) and demonstrated 
that both of these PLA2 enzyme preparations catalytically hydrolyze essentially only the R 
synthetic L654 (data not shown).   
 
Lipid 430 is a Hydrolysis Product of Lipid 654 
The sections above have highlighted a few questions that need to be addressed: 1) If Lipid 430 is 
driving periodontal disease, would it be important to examine bacterial Lipid 430 levels to assess 
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pathogenicity?  2) If Lipid 654 is driving periodontal disease, why do healthy gingival tissues 
and diseased gingival tissues have similar levels?  The answer to the first of these questions is 
found in the fact that, as noted above, Lipid 430 is a hydrolysis product of Lipid 654.  Lipid 430 
itself is found in extremely low levels in bacterial lipid extracts.  This can be seen clearly in 
Figure 4 where Lipid 430/Lipid 654 ratios are assessed in multiple oral bacteria.  Interestingly, 
Lipid 430/Lipid 654 ratios are much higher in tissue samples (see Figure 5).   
 
Figure 4.  L430/L654 ratios in lipid extracts from oral and gastrointestinal Bacteroidetes.  
Bacteria samples were obtained from cultured organisms or from donated samples.  The P 
gingivalis samples except for the ATCC strain and T. forsythus were obtained from the 
Forsyth Institute, and the intestinal Bacteroidetes were obtained from Dr. Sid Finegold.  
Bacterial samples were extracted using the Bligh and Dyer procedure and the extacted 
lipids were analyzed by MRM-MS 1.   
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Figure 5.  L430/L654 ratios in lipid extracts from bacteria, carotid artery, gingival tissue, 
plaque and calculus samples.   Bacteria samples shown in Figure 3 were averaged and 
depicted at left.   Tissue samples were obtained at the time of surgical excision and were 
frozen until the time of processing.  Subgingival calculus samples were obtained from 
extracted teeth and plaque samples were obtained with endodontic paper points from 
severe periodontitis sites of two subjects. The control carotid artery samples were obtained 
from the National Disease Research Interchange (Philadelphia, PA).  Gingival tissue 
samples were obtained from either healthy (GT Control) or chronic periodontitis (GT 
Perio) sites.  All samples were extracted using the Bligh and Dyer procedure and the 
extracted lipids were analyzed by MRM-MS for quantification of L430 and L654 1. 
 
These findings suggest that Lipid 654 is hydrolyzed to Lipid 430 within tissues.  As for the 
second question posed – the answer can be found by revisiting one of the properties of Lipid 654 
noted above.  Specifically, Lipid 654 may be synthesized as two isoforms differing in the R and S 
configuration in the beta carbon of the 3-OH iso C17:0 fatty acid.  Because serine is recovered in 
Lipid 654 as the L enantiomer, Lipid 654 containing (R) and (S) isoforms represent diastereomers.  
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The important distinction between these two forms that has not yet been brought up, is that only 
the R form appears to be hydrolyzed by lipase enzymes, specifically PLA2.  Preliminary work 
using a new mass spectrometric analytic approach utilizing differential ion mobility MRM 
suggested the presence of two isoforms of Lipid 654 in a purified preparation of Lipid 654 from 
P. gingivalis (ATCC 33277). (see Figure 6).  At the same time, inactive Lipid 654 samples have 
equal levels of the R and S isoform.  It can also be seen that treating the active Lipid 654 samples 
with phospholipase A2 will hydrolyze the excess R isoform, and only the R isoform, until both 
forms are present in equivalent amounts.   These results form the basis for suggesting that R 
Lipid 654 is preferentially hydrolyzed by PLA2.  Therefore, differences in the recovery or R 
versus S Lipid 654 in various isolates of bacterial Lipid 654 could account for the differences in 
biological activity between these preparations.   
Figure 6.  Relative levels of R and S isoforms of Lipid 654 in active, inactive and PP PLA2 
treated Lipid 654 samples.   
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To examine the biological relevance of this hydrolysis, synthetic R and S Lipid 654 preparations 
were analyzed for catalytic hydrolysis by bone marrow macrophages.   A shown in Figure 7, 
recovery of Lipid 654 and lipid 430 is frequently less in TLR2 knockout cells compared with 
wild type cells.  The ratio of Lipid 430 to Lipid 654 was substantially less in the TLR2 knockout 
cells than the wild type cells.   This suggests that cell-mediated hydrolysis of Lipid 654 is at least 
partially enantioselective, similar to that observed with PLA2 hydrolysis of these synthetic 
standards.   
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Figure 7A-C.  Recovery of Lipid 430 and Lipid 654 in bone marrow macrophages and 
media samples after exposure to R or S Lipid 654 as well as bacterial Lipid 654.   Fig. 7A 
shows the recovery of Lipid 654 and Fig. 7B shows the recovery of Lipid 430 in cells and 
media samples.  Fig. 7C shows the difference between Lipid 430/Lipid 654 ratios when cells 
are treated with either R or S Lipid 654.  Bone marrow macrophages were incubated for 24 
hour with the indicated lipid preparations.  Media samples were harvested and the cells 
washed twice with PBS.  The cells were then scraped in PBS and transferred to glass tubes 
for lipid extraction.  Both media and cell samples were acidified with acetic acid and 
extracted chloroform.  The samples were dried and analyzed by MRM ESI as previously 
described.   
11 
 
Identification of Bacterial Taxa via 16S Ribosomal RNA Sequencing 
As noted above, approximately one third of the bacteria that have been identified to reside in the 
human oral cavity are currently uncultivable11.  These bacterial phyla have been identified 
through sequencing methods that allow investigators to uniquely identify bacterial phyla by the 
sequence of their 16S rRNA gene.  The 16S rRNA gene codes for the 16S ribosomal RNA 
molecule.  This is the portion of the 30S small subunit of the prokaryotic ribosome which binds 
to the Shine-Dalgarno sequence in order to initiate translation (see Figure 8).   
This gene can be used to phylotype bacteria because portions of it have very slow rates of 
evolution.  Carl Woese first developed the use of 16S rRNA gene sequences to phylotype 
bacteria by taking advantage of highly conserved regions within 16S rRNA introns12.  Universal 
primer pairs which anneal to these highly conserved areas were first developed by Weisburg et 
al13.  The primers developed by Weisburg were the 27F forward primer and 1492R primer which 
were used to amplify 1465 base pair amplicons. These amplicons contained highly variable 
regions of the 16S rRNA gene that could be used to uniquely identify bacterial taxa (see Figure 
9).  Sequencing of these highly variable regions, which uniquely identify bacterial phyla, is made 
possible by taking advantage of highly conserved regions within the gene which allow for 
sequencing primers to anneal.  Because previous studies have associated bacterial phyla with 
their specific 16S rRNA gene sequences, the sequencing reads obtained from unknown bacterial 
populations can be identified using a Basic Alignment Search Tool (BLAST) to align the 
unknown sequence with one in a database – uniquely identifying the bacteria from which that 
sequence came. 
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Figure 8.  Secondary structure of 16S rRNA molecule14.   
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Amplification and sequencing of the 16S rRNA gene can be used either to identify new bacteria 
(as phyla can be classified based on sequences) or to confirm the presence of bacteria in a sample 
population.  In the case of this study, this sequencing technique will be utilized to confirm the 
purity of cultures grown up for lipid extraction.   
 
 
 
Figure 9.  Areas of sequence conservation along the 16S rRNA gene allow for amplification 
of sequence containing highly variable regions which allow for phylotyping13. 
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RATIONALE 
Given the possible role of both Lipid 654 and Lipid 430 in the pathogenesis of periodontal 
disease as well as multiple sclerosis outlined above, further investigation into the mechanism of 
action of these lipids is clearly warranted.  Most importantly, it is necessary to investigate 
whether the presence or absence of the R and S isoforms plays a role in the pathogenicity of these 
Lipids.  Understanding the role these different isoforms play and which bacteria contain them 
will provide a better understanding of the disease pathogenesis.  This information, in turn, will 
provide a better understanding of how to counteract their effects.  Specifically, understanding 
which bacteria are more or less pathogenic in these diseases may allow for manipulation of the 
oral and gut microbiome to aide in disease prevention. 
 
CHAPTER II:  HYPOTHESIS AND AIMS 
Hypothesis 
We hypothesize that the relative levels of the R and S isoforms of Lipid 654 will vary among 
different Bacteroidetes present in the oral cavity, particularly those associated with chronic 
inflammatory periodontal disease.   
 
Specific Aims 
To determine the distribution of Lipid 654 R and S isoforms in Bacteroidetes known to produce 
Lipid 654. This aim is proposed because two isoforms have been identified in P. gingivalis lipid 
extracts and these isoforms vary in biological activity and enzyme susceptibility, both of which 
15 
 
may be important in the potential for specific Bacteroidetes to promote disease through this lipid 
class. We will determine the distribution of R and S isoforms of Lipid 654 produced by oral 
Bacteroidetes species and whether the isoforms of Lipid 654 recovered in dental tissues represent 
the two enantiomeric forms derived from P. gingivalis and perhaps other oral Bacteroidetes.  
Specifically, we will analyze oral isolates of P. gingivalis previously obtained from the Forsyth 
Institute and compare them with ATCC #33277. We will also analyze P. gingivalis isolates of 
381, W83 and W50 strains obtained from ATCC as well as Prevotella intermedia, and 
Tannerella forsythia. 
 
CHAPTER III:  MATERIALS AND METHODS 
Growth of Bacterial Cultures 
Bacteria were inoculated into liquid basal medium (peptone, trypticase and yeast extract) 
supplemented with hemin, menadione (Sigma-Aldrich), and brain heart infusion (BHI).  Bacteria 
were cultivated in liquid broth – being incubated for four days in an anaerobic chamber flushed 
with N2 (80%), CO2 (10%), and H2 (10%) at 37oC.  Cultures were then harvested by 
centrifugation at 2000 x g for 2 hours.  Bacterial pellets were then lyophilized to prepare for lipid 
extraction.  Culture purity was verified by 16S rRNA gene amplification and sequencing as 
outlined below. 
 
Verification of Culture Purity 
Culture purity was verified using amplification and sequencing of the 16S rRNA gene from the 
bacterial pellets obtained.  Amplification via touch PCR (polymerase chain reaction) was 
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performed using GoTaq Green Master Mix (Promega Corporation, Madison, WI).  50µl reaction 
mixtures were made as seen in Table 1.   
GoTaq Green Mastermix 25µl 
Upstream primer (10pmol/µl) 2µl 
Downstream primer (10pmol/µl) 2µl 
H2O 18.5µl  
MgCl2 (50mM) 2.5µl  
Table 1. PCR Reaction Setup 
The upstream and downstream primers referred to in Table 1 are the universal forward and 
reverse 16S rRNA primers seen in Table 2.  These primers have been shown to be universally 
effective in the amplification of the 16S rRNA gene from a broad spectrum of bacteria15.   
Primer Name  Sequence Orientation Comments 
Universal 
Forward 
GAGTTTGATYMTGGCTC
AG 
Forward Amplification of 16S 
rRNA gene 
Universal 
Reverse 
GHTACCTTGTTACGACTT Reverse Amplification of 16S 
rRNA gene 
AE50 TKACCGCGGCTGC Reverse Sequencing Primer at bp 
521-533 
Table 2. Primer Chart 
 
Touch PCR was performed using sterilized glass pipettes to add template DNA from lyophilized 
bacterial pellets to each 50µl reaction mixture.  PCR reactions were run in thin walled tubes 
using a PCR Sprint Thermal Cycler (Thermo Fisher Scientific, Waltham, MA).  A hot start 
protocol was utilized allowing the wells to reach 95oC before the tubes were taken off of ice. 
17 
 
PCR cycling protocol was as follows: 95oC for 10 minutes; 30 cycles of 95oC for 45 seconds, 
60oC for 45 seconds, 72oC for 2 minutes; 72oC for 15 minutes. 
Once PCR was completed, samples were shipped to GeneWiz (GeneWiz, South Plainfield, NJ) 
for PCR clean up and sequencing with reverse sequencing primer AE50 (see Table 2).  Primer 
AE50 allowed sequencing of approximately the first 500 base pairs which were enough to 
phylotype the parent bacteria.  Upon receipt of the sequencing reads from GeneWiz in the form 
of ab1 trace files, all files were downloaded.  These files, which contained the chromatograms 
obtained from sequencing the first 500 base pairs of the amplicon produced in the steps above, 
were opened using Chromas sequencing software (Technelysium, South Brisbane, Australia).  
Chromatograms were inspected for double reads and trimmed as follows. 
First, all chromatograms were inspected to see if single or multiple reads were present (see 
Figure 10).  Single reads indicated that a single 16S rRNA gene had been amplified – a result 
consistent with a culture with only one bacterial species present.  Chromatograms with 2 or more 
overlapping reads indicated that the culture had been contaminated by another species.  
Unfortunately, there was no way to untangle the multiple reads to determine which species had 
been cultured along with the intended bacterial species.   
Chromatograms showing single reads were used to trim obtained sequence to remove bases that 
could not clearly be identified by the software.  Generally, these trimmed bases included the first 
30 base pairs read – which are usually of poor quality in Sanger sequencing – as well as the end 
of the chromatogram extending beyond the first base of the amplicon being sequenced.  Figure 
11 shows an example of base pairs selected to be removed from the first 30 base pairs of a 
sample read. 
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Figure 10.  Box A depicts a chromatogram with one read.  This chromatogram is indicative 
of a single amplicon having been sequenced – consistent with the presence of one bacterial 
species in the original culture. Box B depicts a chromatogram with 2 distinct reads.  Note 
the double peaks present.  This chromatogram is consistent with the presence of multiple 
amplicons, indicating that multiple bacterial species were present in the original culture.   
 
 
  
 
Figure 11.  Base pairs 1-30 are trimmed from a sample .ab1 file due to poor reads.  As can 
be seen, the software is unable to make a clear call on which base pair is present. 
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Once the sequence reads had been trimmed, the remaining 400-500 base pairs of quality 
sequence were used in a BLAST analysis to find significant alignments between the sequence 
obtained and the 16S rRNA gene library of the Greengenes database at greengenes.lbl.gov16,17.  
Alignments between the obtained sequence and a database match were displayed as seen in 
Figure 12.  Alignments of greater than 99% were considered to confer identification of the parent 
bacteria.   
 
 
Figure 12.  Table from BLAST search against Greengenes 16S rRNA gene database.  
Matches of greater than 99% were assumed to confer identity of the parent bacteria.   
 
 
 
Lipid Extraction and Semipreparative HPLC Fractionation 
To begin the extraction of bacterial lipids from the lyophilized bacterial pellets, the bacterial 
samples were first weighed.  Each 2g of bacterial pellet was then suspended in 16ml of 
chloroform:methanol:water in a ratio of 1.33:2.67:1 (v/v/v).  This mixture was vortexed every 15 
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minutes for 2 hours and then supplemented with 6ml of chloroform and 6ml of 2N of KCl + 
0.5N K2HPO4.  The mixture was once again vortexed and centrifuged at 2000 x g for 4 hours at 
20oC.  At this time, the lower organic phase was collected, dried under nitrogen, and 
reconstituted into 24ml of the following HPLC solvent: hexane:isopropanol:water in a ratio of 
6:8:0.75 (v/v/v).  This mixture was then centrifuged at 2500 x g for 10 minutes and the 
supernatant was collected from HPLC analysis.  Semipreparative HPLC fractionation was then 
performed using a Shimadzu 10ADvp HPLC system.  Lipid fractionation was performed using 
normal phase isocratic separation (Ascentis Si, 25cm x 10mm, 5µm, Sigma-Aldrich) with a flow 
rate of 1.8ml/min.  Fractions were collected in 1 minute increments and effluent was monitored 
at 205nm as shown in Figure 13.  After pooling replicate fractions, they were dried under 
nitrogen and reconstituted in HPLC solvent (hexane:isopropanol:water mixture as mentioned 
above) for mass spectrometric analysis.  This analysis is described below.  Fractions which were 
determined to contain Lipid 654 by ESI MRM analysis were pooled and dried before further 
acidic HPLC fractionation to separate serine lipids from phospholipids of similar structure. 
 
 
 
Figure 13.  Total lipids of P. gingivalis fractionated by normal phase HPLC. The fractions 
containing Lipid 654 are shown.18 
 
21 
 
Mass Spectrometry 
Mass spectrometry was performed by applying lipids from recovered HPLC fractions to a 
normal phase column (Ascentis Si, 3cm x 2.1mm, 5µm, Sigma Aldrich) connected to an Qtrap 
4000 instrument (Sciex, Framingham, MA).  Under isocratic conditions, neutral HPLC solvent 
was delivered at a flow rate of 100-120 µl/min using a Shimadzu LC-10ADvp pump.  Using a 
mass range of 100 to 1600 amu, and MS/MS acquisition parameters optimized for specific lipid 
products, total ion chromatograms were obtained.  Negative ion ESI was carried out at -4500 V 
with a focusing potential of -10 V, a declustering potential of -90V, and an entrance potential of -
10 V.  Collision energies for negative ion products ranged from -30 to -55 volts.  The MRM 
negative ion transitions which were monitored for Lipid 654 were m/z 653.5/131.1, 653.5/306.2, 
and 653.5/381.4.   
 
 
 
Figure 14.  MS spectrum of Lipid 654.18 
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Acidic HPLC Fractionation 
To further purify Lipid 654 from co-eluting lipids after initial fractionation, acidic HPLC 
fractionation was performed.  Acidic HPLC allowed Lipid 654 to be separated from co-migrating 
phospholipids.  To perform this separation, the factions from the previous semipreparative HPLC 
which contained Lipid 654 were pooled, dried under nitrogen, and reconstituted in the same 
HPLC solvent used above [hexane:isopropanol:water in a ratio of 6:8:0.75 (v/v/v)] with the 
addition of 0.1% acetic acid.  This mixture was then fractionated once again using the same 
Shimadzu 10ADvp HPLC system along with the same normal phase HPLC column (Ascentis Si, 
25cm x 10mm, 5µm, Sigma-Aldrich).  The flow rate was 1.8ml/min and fractions were collected 
in 1 minute increments.  Lipid 654 eluted in the 10-12 min fractions, ahead of other 
phospholipids which eluted at later time points.  Fractions containing Lipid 654 were collected, 
pooled, and refractionated in order to produce a highly enriched Lipid 654 sample as illustrated 
in Figure 15.  This enriched sample was finally divided into 250µg aliquots. 
 
 
 
Figure 15.  Enriched Lipid 654 sample obtained from acidic HPLC fractionation.18 
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Chiral HPLC Fractionation 
 
Once an enriched Lipid 654 sample was obtained, the R and S isoforms were separated via chiral 
HPLC fractionation.  The enriched Lipid 654 sample was dried and reconstituted in a solvent 
composted of hexane:isopropanol, 9:1 (v/v) and supplemented with 0.1% diethylamine.  
Fractionation was performed by eluting the enriched sample over a LUX-cellulose 4 (25 cm x 
4.6 mm, 10µm, Phenomenex, Torrence, CA) at a flow rate of 0.6ml/ min.  The effluent was 
monitored at 205nm.   A racemic mixture of synthetic L-serine-(R)- and (S)-Lipid 654 was 
prepared as reported by Deitz et al19 for use as a standard to demonstrate at which time points the 
R and S isoforms elute.  This standard was run over the same column and chromatograms were 
compared to see relative levels of R and S isoforms recovered from the enriched samples. 
 
Chapter IV:  RESULTS 
 
Cultures were inoculated, incubated, and tested for verification of purity as described above for 
eleven common oral bacteria.  Results for culture purity are depicted below in Table 3.  Final 
trimmed 16S rRNA gene sequence reads obtained with sequencing primer AE50 may be found 
in Appendix I.  BLAST results against the Greengenes database may be found in Appendix II.   
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Sample Description Greengenes BLAST result  % Match 
Porphyromonas gingivalis 
ATC33277 Porphyromonas gingivalis ATC33277 100 
Porphyromonas gingivalis 0450* Porphyromonas catoniae   94.53 
Porphyromonas gingivalis 4087 Porphyromonas gingivalis W83 99.5 
Porphyromonas gingivalis 0568 Porphyromonas gingivalis W83 99.56 
Porphyromonas gingivalis 0569  Porphyromonas gingivalis W83 99.78 
Porphyromonas gingivalis 381 Porphyromonas gingivalis FDC 381  99.57 
Porphyromonas gingivalis W83 Porphyromonas gingivalis W83 100 
Prevotella intermedia Two reads present after bp 290   
Porphyromonas gingivalis 0570  Porphyromonas gingivalis W83 99.5 
Porphyromonas gingivalis 0580  Multiple matches- none were Porphyromonas gingivalis    
Tannerella forsythia Tannerella forsythia 100 
Table 3. 
*BLAST result against Greengenes database returned a match with less than the 99% homology required to confirm 
strain identity.  
 
As can be seen above in Table 3, most strains returned BLAST results with the required 99% 
homology match required to confirm sequence identity.  The two notable exceptions were the P. 
gingivalis strain 0450 and P. intermedia obtained from the late Ed Moore of VPI.  In the first 
case, the trimmed sequence read obtained for P. gingivalis strain 0450 was used in a BLAST 
search against the Human Oral Microbiome Database.11,15  This BLAST search returned a 
homology match of 98.7% against “Porphyromonas sp. Strain_F0450c,” confirming that the 
culture was a pure culture of the intended species.  In the case of the P. intermedia culture, the 
ab1 files analyzed by Chromas showed 2 reads after base pair 290.  The 260 base pairs of quality 
read (the first 30 base pairs were removed due to poor quality as described above) returned a 
BLAST search result showing homology to Prevotella  nigrescens.  These BLAST results may 
also be found in Appendix II.   
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At the time of this writing, not all cultures had undergone lipid extraction, Lipid 654 enrichment  
and separation of R and S Lipid 654 isoforms as outlined above.  The results for those samples 
which have been completed are shown below in Table 4.   
Sample R-isoform % S-isoform % 
Porphyromonas gingivalis ATC33277* 100 0 
Porphyromonas gingivalis 0450* 100 0 
Porphyromonas gingivalis 0569  100 0 
Porphyromonas gingivalis W83* 100 0 
Prevotella intermedia* 100 0 
Porphyromonas gingivalis 0570  100 0 
Porphyromonas gingivalis 0580* 100 0 
Table 4.  Relative percentage of R and S isoform Lipid 654 present in multiple oral 
Bacteroidetes species.  Results for the species above with an asterisk (*) present were taken 
from unpublished work by Reza Nemati.20 
 
Much of the data presented in Table 4 came from unpublished work done by Reza Nemati.20  
Chiral HPLC chromatographs used to analyze lipid samples from the other bacterial species can 
be found in Appendix III.   
 
CHAPTER V:  DISCUSSION AND CONCLUSION 
Relevance and Summary of Findings 
Lipid 654 is a serine dipeptide lipid that has been shown to play a key role in inflammatory 
disease.1,6  While originally thought to act through TLR4 receptors,4,5 the mechanism of action 
for Lipid 654 has been demonstrated to work by engaging TLR2 receptors.  Through TLR2 
activation, Lipid 654 has been demonstrated to directly inhibit osteoblast differentiation,21 
further bolstering the idea that Lipid 654 from P. gingivalis plays a key role in periodontitis.  
Despite these findings, gingival tissue samples taken from both healthy and diseased tissues 
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show similar levels of Lipid 654 present.  This finding in itself seems to refute Lipid 654 as a 
pathogen in periodontitis, until you consider the fact that two forms of the Lipid exist; 
enantiomers differing in the R and S configuration in the beta carbon of the 3-OH iso C17:0 fatty 
acid.  A closer look at these enantiomers reveals that only one, the R isoform, can be cleaved to 
generate the de-esterified hydrolysis product Lipid 430.  This hydrolysis reaction is catalyzed by 
Phospholipase A2 (PLA2), which is in itself a very significant finding as Lipid 654 is not a 
phospholipid and also does not contain a glycerol moiety.   
Lipid 430, much like Lipid 654, has been shown to elicit inflammatory responses via TLR2 
activation21.  With regard to its potential role in periodontitis, Lipid 430 has also been shown to 
inhibit osteoblast differentiation and function.  Unlike Lipid 654, Lipid 430 is present at 
extremely low levels in bacterial lipid extracts.  While Lipid 430 levels are also extremely low in 
blood samples, they begin to show up in tissue samples. This evidence suggests that the 
hydrolysis of Lipid 654 to produce Lipid 430 occurs within tissues. 
To sum up these findings, if Lipid 430 is the pathogen responsible for bone loss in periodontitis, 
and Lipid 430 is a hydrolysis of the R isoform, and only the R isoform, of Lipid 654, then it is the 
presence of this R isoform of Lipid 654 in bacterial lipids that is responsible for pathogenesis.  
This demonstrates the need to understand which oral bacteria contain which isoforms of Lipid 
654.   
Our results show that the seven species tested so far contain only the R isoform.  This is in 
contrast to our hypothesis that the relative levels of both isoforms would vary among different 
species – but is an important finding nonetheless.   
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Purity of Tested Cultures 
Each of the eleven cultures grown were tested for culture purity using PCR techniques outlined 
above.  Of the eleven, eight cultures had one clear sequencing read with greater than 99% match 
in the Greengenes database to the bacterial species intending to be cultured.  The single read 
indicated that only one 16S rRNA gene was amplified, thereby confirming the presence of only 
one bacterial species in the culture.  There were three cultures for which culture purity could not 
be verified.  These cultures are outlined below: 
1) P. gingivalis 0450:  Sequencing results with the AE50 primer (see Table 2) showed that 
one 16S rRNA gene was amplified from this culture – consistent with one species being 
present in the culture.  However, when a BLAST search was performed with the 
sequence against the Greengenes database, no match was present with homology greater 
than the 99% cutoff.  In this case, the trimmed read was then used in a BLAST search 
against the Human Oral Microbiome (HOMD) database.  Against the HOMD database, 
the read produced a 98.7% match for “HOT_279 (Porphyromonas sp. Strain_F0450c),” 
thereby verifying that the intended species had been grown.  BLAST results against the 
HOMD database may be found in Appendix II. 
2) P. intermedia:  Sequencing results with the AE50 primer showed two overlapping reads 
present after base pair 290.  This is consistent with either a contaminating bacterial 
species in the culture or mispriming of either the sequencing or amplification primers.  
The single read present from the 260 base pairs of quality read was used in a BLAST 
search against the Greengenes database and returned a greater than 99% homology match 
against P. nigrescens.  BLAST results may be found in Appendix II. 
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3) P. gingivalis 0580:  Sequencing results with the AE50 primer were used in a BLAST 
search against the Greengenes database and returned matches with greater than 99% 
homology against multiple species – none of which were the intended species.  These 
species included: Bifidobacterium urinalis, Metascardovia creceti, and Alloscardovia 
omnicolens.  More detailed analysis of which species was present could be determined by 
fully sequencing the amplified 16S rRNA gene – but this was not deemed necessary.  The 
culture was not of the intended species.  BLAST results may be found in Appendix II. 
 
Shortcomings in Verification of Culture Purity 
The greatest shortcoming in the method chosen for verification of culture purity is that it 
completely depends on the ability of the universal forward and reverse primers used (see Table 
2) for amplification of the 16S rRNA gene to anneal to and amplify this gene from any 
contaminating species.  While the selected primers have been shown to amplify the 16S rRNA 
gene of a wide range of bacterial species, previous oral microbiome studies have shown a few 
rare phyla are not detected with these primers.22  Despite this, PCR amplification of the 16S 
rRNA gene has been validated as a reliable method for detection of bacterial contamination.23   
 
Future Directions 
Following the work that has been completed thus far, the next step taken would be to extract 
lipids and determine the relative levels the R and S isoforms of Lipid 654 present in the remaining 
four cultures that have been grown and purified: P. gingivalis 0487, P. gingivalis 0568, P. 
gingivalis 381, and T. forsythia.  After this, other bacterial species may be analyzed including 
Prevotella intermedia, Tannerella forsythia, Capnocytophaga species, and Treponema denticola.  
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The future goal of this research is to find species with varying levels of Lipid 654 R and S 
isoforms and see if these levels vary along with pathogenicity of the host bacteria.  
If such a relationship can be found between the relative levels of the R and S isoforms of Lipid 
654 and the pathogenicity of the host bacteria, the next logical step would be to investigate how 
this information could be used to mitigate or fully prevent diseases involving Lipid 654.  The 
possibility of mitigating and preventing diseases such as periodontitis and multiple sclerosis 
surely warrant further investigation of these lipids. 
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Chapter VII:  APPENDICES 
 
Appendix I  
Trimmed sequence reads obtained from sequencing with primer AE50 as described above are 
listed below for each bacterial culture.  Each read is listed under the bacteria which was intended 
to be cultured. 
Porphyromonas gingivalis ATC33277 
AAGAAGTTTACAATCCTTAGGACAGTCTTCCTTCACGCGACTTGGCTGGTTCAGGCT
CTCGCCCATTGACCAATATTCCTCACTGCTGCCTCCCGTAGGAGTCTGGTCCGTGTCT
CAGTACCAGTGTGGGGGATAAACCTCTCAGTTCCCCTACCCATCGTCGCCTTGGTGA
GCCGTTACCTCACCAACTAGCTAATGGGACGCATGCCTATCTTACAGCTATAAATAT
TTCCTTGTAATATCATGCAATAATACAAGTGTATGCGGTTTTAGTCCGTCTTTCAACG
GGTTATCCCCCTCTGTAAGGCAAGTTGCATACGCGTTACGCACCCGTGCGCCGGTCG
CCATCAACCTTAGCAAGCTAAGATCATGCTGCCCCTCGACTTGCATGTGTTAAGCCT
ATCGCTAGCGTTCATCCTGAGCCAGGATCAAACT 
 
Porphyromonas gingivalis 0450 
TCATCCTTCACGCGACTTGGCTGGTTCAGGCTCTCGCCCATTGACCAATATTCCTCAC
TGCTGCCTCCCGTAGGAGTCTGGTCCGTGTCTCAGTACCAGTGTGGGGGTTCAACCT
CTCAGTTCCCCTACCCATCGTCGCCTTGGTGAGCCGTTACCTCACCAACTAGCTAAT
GGGACGCATGCCTATCTCACAGCGAATTTCATTTCCTTTACGTTGGATGCCCACCAT
GAAGTGTACGCGGTATTAGTCCGTCTTTCGACGGGTTATCCCCCTCTGTGAGGCAAG
TTGCATACGCGTTACGCACCCGTGCGCCGGTCGCCATCAGTCTTAGCAAGCTAAGAC
CATGCTGCCCCTCGACTTGCATGTGTTAAGCCTATCGCTAGCGTTCATCCTGAGCCAT
GATCAAACTCA 
 
Porphyromonas gingivalis 4087 
TTCATGCATACTCGTATCGCCCGTTATTCCCGTATAAAAGAAGTTTACAATCCTTAGG
ACTGTCTTCCTTCACGCGACTTGGCTGGTTCAGGCTATCGCCCATTGACCAATATTCC
TCACTGCTGCCTCCCGTAGGAGTCTGGTCCGTGTCTCAGTACCAGTGTGGGGGATAA
ACCTCTCAGTTCCCCTACCCATCGTCGCCTTGGTGAGCCGTTACCTCACCAACAAGC
TAATGGGACGCATGCCTATCTTACAGCTATAAATATTTCCTTGTAATATCATGCAAT
AATACAAGTGTATGCGGTTTTAGTCCGTCTTTCAACGGGTTATCCCCCTCTGTAAGGC
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AAGTTGCATACGCGTTACGCACCCGTGCGCCGGTCGCCATCGACCTTAGCAAGCTAA
GATCATGCTGCCCCTCGACTTGCATGTGTTAAGCCTATCGCTAGCGTTCATCCTGAGC
CAGGATCAAACTC 
 
Porphyromonas gingivalis 0568 
GCAATACTCGTATCGCCCGTTATTCCCGTATAAAAGAAGTTTACAATCCTTAGGACT
GTCTTCCTTCACGCGACTTGGCTGGTTCAGGCTCTCGCCCATTGACCAATATTCCTCA
CTGCTGCCTCCCGTAGGAGTCTGGTCCGTGTCTCAGTACCAGTGTGGGGGATAAACC
TCTCAGTTCCCCTACCCATCGTCGCCTTGGTGAGCCGTTACCTCACCAACCAGCTAAT
GGGACGCATGCCTATCTTACAGCTATAAATATTTCCTTGTAATATCATGCAATAATA
CAAGTGTATGCGGTTTTAGTCCGTCTTTCAACGGGTTATCCCCCTCTGTAAGGCAAGT
TGCATACGCGTTACGCACCCGTGCGCCGGTCGCCATCGACCTTAGCAAGCTAAGATC
ATGCTGCCCCTCGACTTGCATGTGTTAAGCCTATCGCTAGCGTTCATCCTGAGC 
 
Porphyromonas gingivalis 0569  
GCAATACTCGTATCGCCCGTTATTCCCGTATAAAAGAAGTTTACAATCCTTAGGACT
GTCTTCCTTCACGCGACTTGGCTGGTTCAGGCTCTCGCCCATTGACCAATATTCCTCA
CTGCTGCCTCCCGTAGGAGTCTGGTCCGTGTCTCAGTACCAGTGTGGGGGATAAACC
TCTCAGTTCCCCTACCCATCGTCGCCTTGGTGAGCCGTTACCTCACCAACCAGCTAAT
GGGACGCATGCCTATCTTACAGCTATAAATATTTCCTTGTAATATCATGCAATAATA
CAAGTGTATGCGGTTTTAGTCCGTCTTTCAACGGGTTATCCCCCTCTGTAAGGCAAGT
TGCATACGCGTTACGCACCCGTGCGCCGGTCGCCATCAACCTTAGCAAGCTAAGATC
ATGCTGCCCCTCGACTTGCATGTGTTAAGCCTATCGCTAGCGTTCATCCTGAG 
 
Porphyromonas gingivalis 381 
TTCAATGCAATACTCGTATCGCCCGTTATTCCCGTATAAAAGAAGTTTACAATCCTTA
GGACAGTCTTCCTTCACGCGACTTGGCTGGTTCAGGCTCTCGCCCATTGACCAATATT
CCTCACTGCTGCCTCCCGTAGGAGTCTGGTCCGTGTCTCAGTACCAGTGTGGGGGAT
AAACCTCTCAGTTCCCCTACCCATCGTCGCCTTGGTGAGCCGTTACCTCACCAACTA
GCTAATGGGACGCATGCCTATCTTACAGCTATAAATATTTCCTTGTAATATCATGCA
ATAATACAAGTGTATGCGGTTTTAGTCCGTCTTTCAACGGGTTATCCCCCTCTGTAAG
GCAAGTTGCATACGCGTTACGCACCCGTGCGCCGGTCGCCATCAACCTTAGCAAGCT
AAGATCATGCTGCCCCTCGACTTGCATGTGTTAAGCCTATCGCTAGCGTTCATCCTG
AGCCAGG 
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Porphyromonas gingivalis W83 
TTCAATGCAATACTCGTATCGCCCGTTATTCCCGTATAAAAGAAGTTTACAATCCTTA
GGACTGTCTTCCTTCACGCGACTTGGCTGGTTCAGGCTCTCGCCCATTGACCAATATT
CCTCACTGCTGCCTCCCGTAGGAGTCTGGTCCGTGTCTCAGTACCAGTGTGGGGGAT
AAACCTCTCAGTTCCCCTACCCATCGTCGCCTTGGTGAGCCGTTACCTCACCAACAA
GCTAATGGGACGCATGCCTATCTTACAGCTATAAATATTTCCTTGTAATATCATGCA
ATAATACAAGTGTATGCGGTTTTAGTCCGTCTTTCAACGGGTTATCCCCCTCTGTAAG
GCAAGTTGCATACGCGTTACGCACCCGTGCGCCGGTCGCCATCAACCTTAGCAAGCT
AAGATCATGCTGCCCCTCGACTTGCATGTGTTAAGCCTATCGCTAGCGTTCATCCTG
AGC 
 
Prevotella intermedia (First 260 base pairs with single read present) 
GGCGCACACGTGCGCCAATTTATTCCCACATAAAAGCAGTTTACAACCCATAGGGCC
GTCATCCTGCACGCTACTTGGCTGGTTCAGACTTGCGTCCATTGACCAATATTCCTCA
CTGCTGCCTCCCGTAGGAGTTTGGACCGTGTCTCAGTTCCAATGTGGGGGACCTTCC
TCTCAGAACCCCTACTGATCGTCGCCTTGGTGGGCCGTTGCCCCGCCAACTAGCTAA
TCAGACGCATCCCCATCCCTTACCGGAAAAA 
Porphyromonas gingivalis 0570  
ACGGTACATTCAATGCAATACTCGTATCGCCCGTTATTCCCGTATAAAAGAAGTTTA
CAATCCTTAGGACTGTCTTCCTTCACGCGACTTGGCTGGTTCAGGCTCTCGCCCATTG
ACCAATATTCCTCACTGCTGCCTCCCGTAGGAGTCTGGTCCGTGTCTCAGTACCAGT
GTGGGGGATAAACCTCTCAGTTCCCCTACCCATCGTCGCCTTGGTGAGCCGTTACCT
CACCAACCAGCTAATGGGACGCATGCCTATCTTACAGCTATAAATATTTCCTTGTAA
TATCATGCAATAATACAAGTGTATGCGGTTTTAGTCCGTCTTTCAACGGGTTATCCCC
CTCTGTAAGGCAAGTTGCATACGCGTTACGCACCCGTGCGCCGGTCGCCATCGACCT
TAGCAAGCTAAGATCATGCTGCCCCTCGACTTGCATGTGTTAAGCCTATCGCTAGCG
TTCATCCTGAGC 
 
Porphyromonas gingivalis 0580  
ACTCACTCACGCTTGCTCCCCAATAAAAGCGGTTTACAACCCGAAGGCCGTCATCCC
GCACGCGGCGTCGCTGCATCAGGGTTCCCCCCATTGTGCAATATTCCCCACTGCTGC
CTCCCGTAGGAGTCTGGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTCAGG
CCGGCTACCCGTCGAAGCCTTGGTAGGCCACTACCCCACCAACAAGCTGATAGGAC
GCGATCCCATCGCATAGCACTAAAACGTTTTCCCACACACCCATGCGAGCATGTGGA
ACATTCGGCATTACCACCCGTTTCCAGGAGCTATTCCAAACTACACGGCAGGTTAAT
CACGCGTTACTCACCCGTTCGCCACTCTCACCCCCCTAGCAAGCTAGAAAGGATCCC
GTTCGACTTGCATGTGTTAAGCACGCCGCCAGCGTTCGTCCTGAGCCA 
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Tannerella forsythia 
TACATGCAATAAAATACACGTATCTCATTTTATTCCCCTGTAAAAGAAGTTTACAAC
CCATAGGGCAGTCATCCTTCACGCGACTTGGCTGGTTCAGGCTCTCGCCCATTGACC
AATATTCCTCACTGCTGCCTCCCGTAGGAGTCTGGTCCGTGTCTCAGTACCAGTGTG
GGGGACCTTCCTCTCAGAACCCCTAACCATCGATGGCTTGGTGAGCCGTTACCTCAC
CAACTACCTAATGGTACGCATGCCCATCCGCAACCAATAAATCTTTAACAAATAGCC
CCATGCGGAACCCCTGTTTTATGAGGTATTAGTCCGACTTTCGCCGGGTTATCCCTCT
GTTGCGGGCAGGTTACATACGCGTTACTCACCCGTGCGCCGGTCGCCGACAGGTATT
GCTACCATCGCTGCCCCTCGACTTGCATGTGTTAAGCCTATCGCTAGCGTTCATCCTG
AG 
 
Appendix II 
BLAST results against the Greengenes database are shown for each read above. Each result is 
shown under the bacteria which was intended to be cultured.  The BLAST results against both 
the Greengenes and Human Oral Microbiome Database are shown for Porphyromonas gingivalis 
0450. 
Porphyromonas gingivalis ATC33277 
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Porphyromonas gingivalis 0450 
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Porphyromonas gingivalis 4087 
 
 
Porphyromonas gingivalis 0568 
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Porphyromonas gingivalis 0569  
 
 
Porphyromonas gingivalis 381 
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Porphyromonas gingivalis W83 
 
 
Prevotella intermedia 
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Porphyromonas gingivalis 0570  
 
 
Porphyromonas gingivalis 0580  
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Tannerella forsythia 
 
Appendix III 
Chromatographs obtained from chiral HPLC as described above. 
Chromatograph obtained from racemic mixture of synthetic R and S isoform Lipid 654 
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Chromatograph obtained from P. gingivalis 0450 Lipid 654 enrichment 
 
 
Chromatograph obtained from P. gingivalis 0569 Lipid 654 enrichment 
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Chromatograph obtained from P. gingivalis 0570 Lipid 654 enrichment 
 
 
